World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01090557
Date of registration: 06/10/2009
Primary sponsor: Winthrop University Hospital
Public title: Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study
Scientific title: A Prospective, Pilot Study Measuring Exhaled Nitric Oxide Levels in Infants and Young Children Admitted to the Hospital for Respiratory Syncytial Virus (RSV) or Other Viral Lower Respiratory Tract Infections
Date of first enrolment: October 2007
Target sample size: 60
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01090557
Study type:  Observational
Study design:  Observational Model: Case Control, Time Perspective: Prospective  
Countries of recruitment
United States
Contacts
Name:   Maria L Quintos-Alagheband, MD
Address: 
Telephone:
Email:
Affiliation:  Winthrop University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Admitted subjects with diagnosis of bronchiolitis, viral pneumonia or other
significant respiratory viral infection

Exclusion Criteria:

- asthma/RAD

- recurrent wheezing

- "recurrent bronchiolitis"

- allergic rhinitis

- atopy

- chronic lung disease

- hypertension

- heart failure

- pulmonary hypertension

- primary ciliary dyskinesia

- bronchiectasis

- alveolitis

- lung transplant rejection

- pulmonary sarcoidosis

- chronic cough (i.e. greater four weeks)

- systemic sclerosis

- hypersensitivity

- cystic fibrosis

- HIV

- sickle cell anemia

- cardiac pulmonary bypass

- liver cirrhosis

- alpha-1 anti-trypsin disease

- interstitial lung



Age minimum: N/A
Age maximum: 4 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Bronchiolitis
RSV Infection
Intervention(s)
Other: Collection of exhaled breath
Primary Outcome(s)
Difference in feNO level between RSV and non-RSV infection in hospitalized pediatric patients with viral lower respiratory illness as well as with control subjects [Time Frame: 2 years]
Secondary Outcome(s)
FeNO levels correlate with the severity of respiratory symptoms in children with acute viral respiratory illness [Time Frame: 2 years]
FeNO levels in viral respiratory illness will vary with steroid use [Time Frame: 2 years]
Secondary ID(s)
07029
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history